IDEX Health & Science acquires thinXXS Microtechnology from Pricap
Hamburg - IDEX Health & Science today announced the acquisition of thinXXS Microtechnology AG. The acquisition is expected to accelerate growth in the microfluidics consumables business. The shareholders of thinXXS Microtechnology AG, including the majority shareholder PRICAP Venture Partners AG, were advised by Heuking Kühn Lüer Wojtek on the sale of their shares to a subsidiary of IDEX Corporation. The parties have agreed not to disclose the purchase price.
thinXXS Microtechnology, based in Zweibrücken, Germany, is a leading company in the development and manufacture of plastic disposable systems for the life sciences, point-of-care and veterinary markets. The acquisition establishes IDEX Health & Science as a technology leader in microfluidics and strengthens its growth focus on integrated optofluidic systems, components and advanced solutions for its target industries.
Advisors to thinXXS Microtechnology AG: Heuking Kühn Lüer Wojtek
Partner Dr. Michael Dröge, Partner Julia Cramer (both lead and M&A/Corporate), Fabian G. Gaffron (Tax), all Hamburg
Dr. Thorsten Kuthe (Stock Corporation Law), Cologne
Dr. Frederik Wiemer (Antitrust Law)
Dr. Florian Wenk, LL.M. (Corporate Law)
Dr. Christina Etzel,
Sven Johannsen (both Vendor Due Diligence), all Hamburg